Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

The randomized controlled trials (RCTs) tested various interventions on pregnant women and preterm infants and high-risk children who received fish oil-derived n-3 fatty acids and vitamin D, probiotics, and palivizumab, motavizumab, and influenza vaccination.

Source: Characteristics of studies on early-life respiratory infections and childhood asthma. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Review / evidence synthesis.

Review / evidence synthesis

Reviews existing research; the exact review methods need further assessment.

Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Publisher article type: systematic-review

Source: Publisher publication metadata.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

The association between early-life respiratory infections and childhood asthma: a meta-analytic perspective

Review / evidence synthesis · Frontiers in Medicine · 2026

Original publication title

The association between early-life respiratory infections and childhood asthma: a meta-analytic perspective

Rong Zhao

Copyright © 2026 Zhao.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Research shows that early-life exposure to viral infections and allergens and environmental pollutants and infant clinical factors establishes strong links to the development of respiratory disorders and allergic diseases in children. The nutritional and probiotic treatments produced restricted and unstable results which demonstrate the requirement for specific preventive methods that should be implemented during early life.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Early-life exposures and interventions establish essential pathways which determine children’s development across respiratory, allergic, and growth pathways. The scientists conducted a systematic review and meta-analysis which combined multiple studies to examine how nutritional interventions and viral prophylaxis and probiotics and environmental exposures and allergen exposures and clinical factors in infants affect asthma and wheeze and atopy and growth outcomes.

Source: Background

Abstract: What methods does the paper describe?

The research team examined 51 studies which they categorized into eight different research areas. The researchers conducted random effects meta-analyses with inverse variance method to calculate pooled odds ratios (ORs) which included 95% confidence intervals (CIs). The researchers used I2 statistics to measure heterogeneity while they used funnel plots and Egger’s test to assess publication bias.

Source: Methods

Abstract: Results

The nutritional interventions during pregnancy (OR = 0.89, 95% CI: 0.74 to 1.07, I2 = 68%) and early probiotics/microbiota modulation (OR = 1.10, 95% CI: 0.84 to 1.43, I2 = 96%) failed to show any significant results. The combination of viral prophylaxis with maternal influenza vaccination protected against wheeze and asthma and LRTI development (OR = 0.78, 95% CI: 0.72 to 0.85, I2 = 68%). The presence of early-life respiratory viral infections raised the likelihood of developing wheeze and asthma (OR = 1.59, 95% CI: 1.39 to 1.82, I2 = 90%) which accompanied allergen/atopy exposures (OR = 1.40, 95% CI: 1.30 to 1.50) and environmental exposures (OR = 1.34, 95% CI: 1.27 to 1.42) and infant clinical factors (OR = 1.29, 95% CI: 1.13 to 1.46, I2 = 82%).

The long-term cohort studies established that early-life risk factors maintain a consistent impact on the development of asthma and allergic conditions (OR = 1.41, 95% CI: 1.35 to 1.48). The studies on viral prophylaxis and respiratory infections and allergen exposure demonstrated evidence of publication bias.

Source: Results

Abstract: Conclusion

Research shows that early-life exposure to viral infections and allergens and environmental pollutants and infant clinical factors establishes strong links to the development of respiratory disorders and allergic diseases in children. The nutritional and probiotic treatments produced restricted and unstable results which demonstrate the requirement for specific preventive methods that should be implemented during early life.

Source: Conclusion
Authors’ abstract

Background

Early-life exposures and interventions establish essential pathways which determine children’s development across respiratory, allergic, and growth pathways. The scientists conducted a systematic review and meta-analysis which combined multiple studies to examine how nutritional interventions and viral prophylaxis and probiotics and environmental exposures and allergen exposures and clinical factors in infants affect asthma and wheeze and atopy and growth outcomes.

Methods

The research team examined 51 studies which they categorized into eight different research areas. The researchers conducted random effects meta-analyses with inverse variance method to calculate pooled odds ratios (ORs) which included 95% confidence intervals (CIs). The researchers used I2 statistics to measure heterogeneity while they used funnel plots and Egger’s test to assess publication bias.

Results

The nutritional interventions during pregnancy (OR = 0.89, 95% CI: 0.74 to 1.07, I2 = 68%) and early probiotics/microbiota modulation (OR = 1.10, 95% CI: 0.84 to 1.43, I2 = 96%) failed to show any significant results. The combination of viral prophylaxis with maternal influenza vaccination protected against wheeze and asthma and LRTI development (OR = 0.78, 95% CI: 0.72 to 0.85, I2 = 68%). The presence of early-life respiratory viral infections raised the likelihood of developing wheeze and asthma (OR = 1.59, 95% CI: 1.39 to 1.82, I2 = 90%) which accompanied allergen/atopy exposures (OR = 1.40, 95% CI: 1.30 to 1.50) and environmental exposures (OR = 1.34, 95% CI: 1.27 to 1.42) and infant clinical factors (OR = 1.29, 95% CI: 1.13 to 1.46, I2 = 82%).

The long-term cohort studies established that early-life risk factors maintain a consistent impact on the development of asthma and allergic conditions (OR = 1.41, 95% CI: 1.35 to 1.48). The studies on viral prophylaxis and respiratory infections and allergen exposure demonstrated evidence of publication bias.

Conclusion

Research shows that early-life exposure to viral infections and allergens and environmental pollutants and infant clinical factors establishes strong links to the development of respiratory disorders and allergic diseases in children. The nutritional and probiotic treatments produced restricted and unstable results which demonstrate the requirement for specific preventive methods that should be implemented during early life.

Publication and source details

Original title: The association between early-life respiratory infections and childhood asthma: a meta-analytic perspective

Rong Zhao

Frontiers in Medicine · 2026

* Correspondence: Rong Zhao, kingmhxywyc@163.comCopyright © 2026 Zhao.2026Zhaohttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:01:32.729946+00:00

DOI: 10.3389/fmed.2026.1751843 · PMC12950688